Regeneron Pharmaceuticals
REGN
#231
Rank
NZ$140.33 B
Marketcap
$1,277
Share price
-1.44%
Change (1 day)
-3.71%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2024 (TTM): NZ$8.01 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are NZ$13.84 Billion. In 2023 the company made an earning of NZ$7.13 Billion a decrease over its 2022 earnings that were of NZ$8.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$8.01 B12.28%
2023 NZ$7.13 B-13.57%
2022 NZ$8.25 B-47.9%
2021 NZ$15.84 B144.75%
2020 NZ$6.47 B56.86%
2019 NZ$4.12 B-4.87%
2018 NZ$4.33 B22.86%
2017 NZ$3.53 B56.3%
2016 NZ$2.26 B8.55%
2015 NZ$2.08 B54.53%
2014 NZ$1.34 B11.14%
2013 NZ$1.21 B72.13%
2012 NZ$0.70 B-285.93%
2011 -NZ$0.38 Billion121.73%
2010 -NZ$0.18 Billion37.18%
2009 -NZ$0.13 Billion-14.6%
2008 -NZ$0.15 Billion-25.02%
2007 -NZ$0.2 Billion6.32%
2006 -NZ$0.19 Billion-186.52%
2005 NZ$0.21 B2103.7%
2004 NZ$9.59 M-105.66%
2003 -NZ$0.17 Billion-18.18%
2002 -NZ$0.21 Billion42.33%
2001 -NZ$0.15 Billion129.35%
2000 -NZ$63.5 Million51.87%
1999 -NZ$41.81 Million92.19%
1998 -NZ$21.76 Million66.23%
1997 -NZ$13.09 Million-55.49%
1996 -NZ$29.41 Million103.53%
1995 -NZ$14.45 Million-70.89%
1994 -NZ$49.63 Million-26.08%
1993 -NZ$67.14 Million114.67%
1992 -NZ$31.28 Million196.77%
1991 -NZ$10.54 Million87.88%
1990 -NZ$5.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$7.95 B-5.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.32 Billion-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.23 B-61.64%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.26 B 270.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.63 B 156.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$12.58 B 49.07%๐Ÿ‡ซ๐Ÿ‡ท France